60 Participants Needed

Exercise Therapy for Parkinson's Disease

Recruiting at 1 trial location
MR
Overseen ByMarc Roig, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: McGill University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This study will investigate the impact of two common exercise modalities, cardiovascular and resistance training, on sleep quality and architecture in persons with Parkinson's disease (PD), and whether these potential positive changes in sleep are associated with improvements in brain plasticity and different quality of life (QoL)-related aspects. Participants will perform either cardiovascular training (CT) or resistance training (RT) for 12 weeks, at least two times/week. The assessments will be performed at baseline and after training by an assessor blinded to the participants' group allocation.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it requires that you have been on a stable dosage of medication for the past month.

What data supports the effectiveness of the treatment Exercise Therapy for Parkinson's Disease?

Research shows that aerobic and resistance training can improve motor symptoms, muscle strength, and quality of life in people with Parkinson's disease. These exercises are safe and beneficial, helping with balance, mobility, and overall fitness.12345

Is exercise therapy safe for people with Parkinson's Disease?

Exercise therapy, including resistance and aerobic training, is generally safe for people with various health conditions, including heart disease and hypertension. Studies show that these exercises can improve muscle strength and cardiovascular health with minimal risk when done under proper guidance.678910

How does exercise therapy differ from other treatments for Parkinson's disease?

Exercise therapy, including cardiovascular and resistance training, is unique for Parkinson's disease as it focuses on improving physical function, balance, and strength through structured physical activity rather than medication. This approach can enhance quality of life and functional capacity without the side effects associated with drugs, making it a beneficial adjunct to traditional treatments.13111213

Eligibility Criteria

This trial is for people with mild to moderate Parkinson's Disease who have poor sleep quality but are on stable medication. They should not be in other drug/exercise trials, have severe untreated sleep apnea, dementia or conditions that prevent exercise. A score >18 on PDSS-2 and <21 on MoCA excludes them.

Inclusion Criteria

My medication dose has been the same for the last month.
My Parkinson's Disease is in the early to middle stages.
You have been diagnosed with significant sleep problems, with a score higher than 18 on a sleep quality test called the PDSS-2.

Exclusion Criteria

You have a Beck Depression Inventory (BDI version 2) score higher than 4.
You have been regularly doing structured exercise at least twice a week for the past two months before joining the study.
I have a health condition that makes it hard for me to exercise.
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants perform either cardiovascular training or resistance training for 12 weeks, at least two times per week

12 weeks
24 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Cardiovascular Training
  • Resistance Training
Trial OverviewThe study tests how cardiovascular (CT) and resistance training (RT) affect sleep quality in Parkinson's patients over 12 weeks of training at least twice a week. It also looks at whether better sleep improves brain function and life quality.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Resistance trainingExperimental Treatment1 Intervention
Resistance training (RT) intensity will be estimated using the percentage of one-maximal repetition (1-RM) defined as the maximal weight liftable for ten maximal repetitions with proper form. The program will include five exercises (leg press, lat machine, leg extension, leg curl, bench press) and will start at high-volume low-intensity. RT will follow a periodization to reach high-intensity low-volume at the end of the intervention (week 12). The training sessions will start with five-minute of warm-up performed on a recumbent stepper and will end with five-minute of stretching (cool-down). RT's sessions will approximately last 45 minutes and will be interspersed with at least 48 hours of recovery.
Group II: Cardiovascular trainingExperimental Treatment1 Intervention
Cardiovascular training (CT) will be performed on a recumbent stepper. CT will start at low intensity, and through a linear progression will reach vigorous intensity; then, this intensity will be maintained until the end of the intervention. Each session will include five minutes of warm-up and cool-down performed at the beginning and the end of the training, respectively. Furthermore, five minutes of stretching will be performed after the cool down. CT's sessions will approximately last 45 minutes and will be interspersed with at least 48 hours of recovery.

Find a Clinic Near You

Who Is Running the Clinical Trial?

McGill University

Lead Sponsor

Trials
421
Recruited
1,017,000+

Jewish Rehabilitation Hospital

Collaborator

Trials
7
Recruited
810+

Findings from Research

Resistance Training (RT) is shown to significantly improve muscle strength in individuals with Parkinson's Disease, with a moderate effect size based on a meta-analysis of 15 randomized controlled trials.
All three exercise modalities—Resistance Training, Endurance Training, and Other Intensive Training Modalities—are safe and feasible, potentially benefiting balance, walking performance, and quality of life in Parkinson's Disease, with no reported deterioration in outcomes.
Parkinson's disease and intensive exercise therapy--a systematic review and meta-analysis of randomized controlled trials.Uhrbrand, A., Stenager, E., Pedersen, MS., et al.[2018]
Resistance training (RT) significantly improves knee extension, knee flexion, and leg press strength in people with Parkinson's disease compared to control groups, based on a systematic review of nine studies.
Combining RT with other forms of exercise, such as aerobic or balance training, leads to even greater improvements in strength, although RT alone may not always outperform other exercise types for certain muscle groups.
Effects of Resistance Training on Measures of Muscular Strength in People with Parkinson's Disease: A Systematic Review and Meta-Analysis.Roeder, L., Costello, JT., Smith, SS., et al.[2018]
Resistance training (RT) and endurance training (ET) are safe and feasible exercise modalities for people with Parkinson's disease, showing significant benefits in muscle strength, functional capacity, and quality of life based on a review of 33 new randomized controlled trials.
RT demonstrated a strong positive impact on muscle strength (SMD = 0.83) and functional capacity, while ET improved cardiorespiratory fitness (SMD = 0.27) and also showed potential benefits for functional outcomes, indicating that both types of exercise can be effective adjunct therapies for managing Parkinson's disease.
Parkinson's disease and intensive exercise therapy - An updated systematic review and meta-analysis.Gamborg, M., Hvid, LG., Dalgas, U., et al.[2022]

References

Parkinson's disease and intensive exercise therapy--a systematic review and meta-analysis of randomized controlled trials. [2018]
Effects of Resistance Training on Measures of Muscular Strength in People with Parkinson's Disease: A Systematic Review and Meta-Analysis. [2018]
Parkinson's disease and intensive exercise therapy - An updated systematic review and meta-analysis. [2022]
Effectiveness of aerobic and resistance training on the motor symptoms in Parkinson's disease: Systematic review and network meta-analysis. [2023]
Is physical exercise beneficial for persons with Parkinson's disease? [2006]
[Heart patient and sports]. [2008]
Blood Flow Restriction Resistance Exercise Improves Muscle Strength and Hemodynamics, but Not Vascular Function in Coronary Artery Disease Patients: A Pilot Randomized Controlled Trial. [2023]
Resistive exercise training in cardiac patients. Recommendations. [2018]
Health- and performance-related potential of resistance training. [2022]
An evidence-based guide to the efficacy and safety of isometric resistance training in hypertension and clinical implications. [2023]
Samba, deep water, and poles: a framework for exercise prescription in Parkinson's disease. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Periodized Resistance Training With and Without Functional Training Improves Functional Capacity, Balance, and Strength in Parkinson's Disease. [2023]
13.United Statespubmed.ncbi.nlm.nih.gov
Effects of moderate-volume, high-load lower-body resistance training on strength and function in persons with Parkinson's disease: a pilot study. [2021]